Clinical Trial Detail

NCT ID NCT03955640
Title Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

breast cancer

Therapies

Olaparib

Age Groups: adult senior

No variant requirements are available.